Essex Woodlands Management as of March 31, 2021
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 9 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| MiMedx (MDXG) | 37.6 | $241M | 23M | 10.30 | |
| Bioventus Com Cl A (BVS) | 28.9 | $185M | 12M | 15.28 | |
| Revance Therapeutics | 12.1 | $77M | 2.8M | 27.95 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 6.7 | $43M | 4.2M | 10.16 | |
| Axogen (AXGN) | 5.6 | $36M | 1.8M | 20.26 | |
| Venus Concept | 4.6 | $29M | 12M | 2.35 | |
| Tela Bio (TELA) | 3.7 | $24M | 1.6M | 14.90 | |
| Medicinova Com New (MNOV) | 0.9 | $5.6M | 1.1M | 5.05 | |
| Catalyst Biosciences Com New | 0.1 | $396k | 79k | 5.04 |
